We use cookies to improve your experience. See our Privacy Policy.
Nexentis Technologies Inc. is a pharmaceutical preparations company incorporated in NV, trading on the Nasdaq.
Brefyr has analyzed 1 SEC filing for NXTS, with the most recent being a 8-K filed on November 6, 2026. Each filing is scored for significance on a 1-10 scale to help investors quickly identify the most important disclosures.
Exchange
Nasdaq
Sector
Healthcare
Filer Category
<br>Emerging growth company
Fiscal Year End
December
| Date | Type | Significance | Details |
|---|---|---|---|
| Nov 6, 26 | 8-K | Routine (0/10) | View |
Nexentis Technologies Inc. is a pharmaceutical preparations company incorporated in NV, trading on the Nasdaq.
Brefyr has analyzed 1 SEC filing for NXTS, including 8-K. The most recent filing was a 8-K filed on November 6, 2026.
No recent insider transactions have been detected in NXTS SEC filings.
Nexentis Technologies Inc. is incorporated in NV and is classified as a <br>Emerging growth company filer with the SEC.
Nexentis Technologies Inc.'s fiscal year ends in December. Annual 10-K reports are typically filed within 60-90 days after the fiscal year end.
Last updated: November 6, 2026
Data sourced from SEC EDGAR public filings. For informational purposes only — not investment advice. AI-generated summaries may contain errors. See our full disclaimer.